Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
In The Last Decade
doi.org/10.1021/ja411006a →Countries where authors are citing Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
This map shows the geographic impact of Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models more than expected).
Fields of papers citing Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
This network shows the impact of Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models.
About Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
This paper, published in 2014, received 872 indexed citations . Written by Rachid Skouta, Scott J. Dixon, Jianlin Wang, Denise Dunn, Marina Orman, Kaoru Shimada, Paul A. Rosenberg, Donald C. Lo, Joel M. Weinberg and Andreas Linkermann covering the research area of Molecular Biology and Nutrition and Dietetics. It is primarily cited by scholars working on Pulmonary and Respiratory Medicine (601 citations), Molecular Biology (536 citations) and Cancer Research (384 citations). Published in Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/ja411006a.